论文部分内容阅读
靶向疗法已经带来在癌症治疗方面的许多重要突破。或许只要再过5年,药物将可能真正个人化——基于一个人的独特基因组,开发适合于这个人的药物。2011年,50岁的美国新罕布什尔州男子詹姆斯·拉格诺的病情很重,医生估计他只剩大约1年的寿命。在他被确诊患有晚期肺癌后,哪怕是最强大的化疗和放疗都无法阻止他的肿瘤变大。雪上加霜的是,他还被确诊患有甲状腺癌。几个月后,他又被诊断患有脑癌。于是,医生建议他考虑写遗嘱。幸运的
Targeted therapies have brought many important breakthroughs in cancer treatment. Perhaps in just over five years, the drug will likely truly personalize - based on one’s unique genome, develop the drug that’s right for that individual. In 2011, James Ragnaud, a 50-year-old New Hampshire man, was seriously ill and doctors estimated he had only about a year left. After he was diagnosed with advanced lung cancer, even the most powerful chemotherapy and radiotherapy failed to stop his tumor from getting bigger. To make matters worse, he was also diagnosed with thyroid cancer. A few months later, he was diagnosed with brain cancer. So, the doctor suggested that he consider writing a will. lucky